Zvast Biotechnology
In vivo pharmacodynamic evaluation refers to the methods used to assess a drug activity, mechanism of action, and efficacy within a living organism, aiming to understand the drug actual effects in the human body. In vivo pharmacodynamic evaluation is a crucial step in the drug development process, helping to screen and optimize candidate drugs while ensuring their safety and effectiveness. With advancements in biotechnology, in vivo pharmacodynamic evaluation methods are moving towards high-throughput, multi-parameter, and multi-target approaches to improve evaluation efficiency and accuracy.
After more than ten years of continuous cultivation and continuous innovation, Zvast Biotech has developed into a comprehensive preclinical CRO company, especially in the field of preclinical pharmacodynamic evaluation services, the breadth and depth of in vivo pharmacodynamic model coverage rank among the forefront of the domestic CRO industry.
We have more than 600 validated disease models covering more than 15 disease areas such as autoimmune diseases/inflammation, tumors and tumor immunity, metabolic diseases (including glucose metabolism, lipid metabolism), liver disease, kidney disease, cardiovascular, ophthalmology, otology, neurology, orthopedics and other surgical fields, forming a brand effect in the industry.
We're here to help! Whether you have questions about our products, need support, or want to share feedback, we'd love to hear from you. Please reach out through any of the methods below, and our team will get back to you as soon as possible.
